James Woodruff Lillie
Chief Scientific Officer at MapLight Therapeutics, Inc. (MPLT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 4SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 22,082202,380 held (−10%) | $12.54 | $277K | -29.6% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 2,238240,491 held (−1%) | $36.00 | $81K | -75.5% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 5,393235,098 held (−2%) | $36.99 | $199K | -76.1% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 12235,086 held (−0%) | $37.54 | $450 | -76.5% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 5,009230,077 held (−2%) | $36.45 | $183K | -75.8% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 3,526226,551 held (−2%) | $37.26 | $131K | -76.3% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 12226,539 held (−0%) | $37.96 | $456 | -76.7% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 2,077224,462 held (−1%) | $37.90 | $79K | -76.7% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 721242,729 held (−0%) | $28.28 | $20K | -68.8% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 9,250285,907 held (−3%) | $27.50 | $254K | -67.9% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 5,526280,381 held (−2%) | $28.37 | $157K | -68.9% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 320280,061 held (−0%) | $29.56 | $9K | -70.1% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 705279,356 held (−0%) | $30.08 | $21K | -70.6% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 10,132269,224 held (−4%) | $28.12 | $285K | -68.6% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 963268,261 held (−0%) | $29.00 | $28K | -69.6% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 8,390259,871 held (−3%) | $28.04 | $235K | -68.5% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 16,421243,450 held (−6%) | $29.13 | $478K | -69.7% |
| Apr 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 1,730297,940 held (−1%) | $26.82 | $46K | -67.1% |
| Apr 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 686297,254 held (−0%) | $27.01 | $19K | -67.3% |
| Apr 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 2,097295,157 held (−1%) | $27.49 | $58K | -67.9% |
- Sell
Chief Scientific Officer James Woodruff Lillie sold $277K of MPLT at $12.54 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer James Woodruff Lillie sold $20K of MPLT at $28.28 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer James Woodruff Lillie sold $254K of MPLT at $27.50 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer James Woodruff Lillie sold $157K of MPLT at $28.37 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer James Woodruff Lillie sold $9K of MPLT at $29.56 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer James Woodruff Lillie sold $21K of MPLT at $30.08 — pre-scheduled 10b5-1 plan sale.